BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 25200966)

  • 1. Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway.
    Zhou J; Yi L; Ouyang Q; Xu L; Cui H; Xu M
    Cell Signal; 2014 Dec; 26(12):2896-902. PubMed ID: 25200966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3.
    Zhang C; Mukherjee S; Tucker-Burden C; Ross JL; Chau MJ; Kong J; Brat DJ
    Mol Oncol; 2017 Mar; 11(3):280-294. PubMed ID: 28100038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p.
    Ouyang Q; Chen G; Zhou J; Li L; Dong Z; Yang R; Xu L; Cui H; Xu M; Yi L
    Neuro Oncol; 2016 Feb; 18(2):216-26. PubMed ID: 26180082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
    Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
    Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of STAT3 expression by RNAi suppresses growth and induces apoptosis and differentiation in glioblastoma stem cells.
    Li GH; Wei H; Lv SQ; Ji H; Wang DL
    Int J Oncol; 2010 Jul; 37(1):103-10. PubMed ID: 20514402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BIS-mediated STAT3 stabilization regulates glioblastoma stem cell-like phenotypes.
    Im CN; Yun HH; Song B; Youn DY; Cui MN; Kim HS; Park GS; Lee JH
    Oncotarget; 2016 Jun; 7(23):35056-70. PubMed ID: 27145367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
    Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
    Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
    Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM
    PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
    Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
    Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel therapeutic target for head and neck squamous cell carcinomas: a role for the neurotensin-neurotensin receptor 1 oncogenic signaling pathway.
    Shimizu S; Tsukada J; Sugimoto T; Kikkawa N; Sasaki K; Chazono H; Hanazawa T; Okamoto Y; Seki N
    Int J Cancer; 2008 Oct; 123(8):1816-23. PubMed ID: 18661521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus infection promotes the formation of glioma stem cells from glioblastoma cells through the TLR9/NEAT1/STAT3 pathway.
    Zang J; Zheng MH; Cao XL; Zhang YZ; Zhang YF; Gao XY; Cao Y; Shi M; Han H; Liang L
    Cell Commun Signal; 2020 Aug; 18(1):135. PubMed ID: 32843056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Positive Feedback Loop Between NTSR1 and Wnt/β-Catenin Contributes to Tumor Growth of Glioblastoma.
    Xiao H; Zeng Y; Wang Q; Wei S; Zhu X
    Cell Physiol Biochem; 2017; 43(5):2133-2142. PubMed ID: 29065410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation by EZH2 activates STAT3 in glioblastoma.
    Cancer Discov; 2013 Jul; 3(7):OF21. PubMed ID: 23847365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of type I interferon on glioblastoma cancer stem cells.
    Du Z; Cai C; Sims M; Boop FA; Davidoff AM; Pfeffer LM
    Biochem Biophys Res Commun; 2017 Sep; 491(2):343-348. PubMed ID: 28728846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
    Leidgens V; Proske J; Rauer L; Moeckel S; Renner K; Bogdahn U; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C
    Oncotarget; 2017 Jan; 8(5):8250-8263. PubMed ID: 28030813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin inhibits tumorigenicity of glioblastoma stem-like cells via the AKT-EZH2-STAT3 signaling axis.
    Chen X; Hao A; Li X; Du Z; Li H; Wang H; Yang H; Fang Z
    J Pineal Res; 2016 Sep; 61(2):208-17. PubMed ID: 27121240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-8, but not the Related Chemokine CXCL1, Sustains an Autocrine Circuit Necessary for the Properties and Functions of Thyroid Cancer Stem Cells.
    Liotti F; Collina F; Pone E; La Sala L; Franco R; Prevete N; Melillo RM
    Stem Cells; 2017 Jan; 35(1):135-146. PubMed ID: 27577959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDGFRα depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals.
    Cenciarelli C; Marei HE; Felsani A; Casalbore P; Sica G; Puglisi MA; Cameron AJ; Olivi A; Mangiola A
    Oncotarget; 2016 Aug; 7(33):53047-53063. PubMed ID: 27344175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coculture with astrocytes reduces the radiosensitivity of glioblastoma stem-like cells and identifies additional targets for radiosensitization.
    Rath BH; Wahba A; Camphausen K; Tofilon PJ
    Cancer Med; 2015 Nov; 4(11):1705-16. PubMed ID: 26518290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice.
    Dupouy S; Doan VK; Wu Z; Mourra N; Liu J; De Wever O; Llorca FP; Cayre A; Kouchkar A; Gompel A; Forgez P
    Oncotarget; 2014 Sep; 5(18):8235-51. PubMed ID: 25249538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.